HK:2617 Stock Latest News
Company AnnouncementsTransThera Wins HKEX Nod for H-Share Full Circulation Conversion13h ago2617
Company AnnouncementsTransThera Sciences Advances Full Circulation Plan for H Shares After CSRC Filing6d ago2617
Company AnnouncementsTransThera launches national rollout of first-in-China cholangiocarcinoma drug Yochanra1w ago2617
Company AnnouncementsTransThera’s Tinengotinib Secures CSCO Guideline Placement for Advanced Biliary Tract Cancers1M ago2617
Company AnnouncementsTransThera Starts Phase II Trial of Tinengotinib Combo in Resistant Prostate Cancer1M ago2617
Company AnnouncementsTransThera Sciences Narrows Interim Loss as Revenue Emerges Amid Rising R&D Spend2M ago2617Company AnnouncementsTransThera Sciences Sets Board Meeting to Review Interim Results and Potential Dividend2M ago2617
Company AnnouncementsTransThera Wins First China Approval for Yochanra in Advanced Cholangiocarcinoma2M ago2617
Company AnnouncementsTransThera Grants Over 5.2 Million H-Share Awards and Options to Staff3M ago2617
Company AnnouncementsTransThera Wins NMPA Nod for Phase II Lung Cancer Trial of TT-00973 Combo3M ago2617
Company AnnouncementsTransThera Completes Global Phase III Enrollment for Tinengotinib in Advanced Cholangiocarcinoma4M ago2617
Company AnnouncementsTransThera Wins China Nod for Phase II Trial of Novel BTK Inhibitor in Mantle Cell Lymphoma4M ago2617
Company AnnouncementsTransThera Sciences to Launch Up to RMB100 Million H-Share Buyback4M ago2617Company AnnouncementsTransThera Sciences Sets Formal Terms for Audit Committee to Strengthen Governance4M ago2617
Company AnnouncementsTransThera Sets Formal Nomination Committee Rules to Strengthen Board Governance4M ago2617
Company AnnouncementsTransThera Sets Board Committee Rules to Tighten Pay and Performance Oversight4M ago2617
Company AnnouncementsTransThera Sets Up Strategy Committee to Tighten Governance and Guide Long-Term Investments4M ago2617- Company AnnouncementsTransThera Wins Shareholder Approval for New H Share Award Scheme4M ago2617
- Company AnnouncementsTransThera Shareholders Back Governance Revamp and Board Changes at 2026 AGM4M ago2617
Company AnnouncementsTransThera Sciences Outlines Board and Committee Structure in Governance Update4M ago2617Company AnnouncementsTransThera Sciences names industry veteran Sun Delong as chief operating officer4M ago2617
Company AnnouncementsTransThera to Showcase Tinengotinib Phase II Data in FGFR2-Altered Cholangiocarcinoma at 2026 ASCO5M ago2617